Effect of a Synbiotic Supplement on a High-protein Diet
Role of Synbiotics on a Weight Loss Intervention Program: Effect on Microbiome
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of the trial is to study how a synbiotic treatment will affect weight loss and management in individuals enrolled in weight loss diet Profile®. The investigators propose to follow up 2 cohorts of Profile® subjects during 6 months. One group will receive a synbiotic treatment supplement (Bifidobacterium spp plus bimuno- galacto-oligosaccharides (B-GOS)) while the other group will receive placebo capsules. Anthropomorphic and metabolic analysis will be performed by-monthly. Fecal samples will be obtained before and after the dietary intervention and samples will be sequenced trough next generation DNA sequencing to analyze the gut microbiota. Because dietary interventions with high protein and low glycemic index have been shown to be effective in reducing weight, but has also been linked to potential colon harm due to increased fermentation of undigested protein on the colon, the investigators expect supplementation of Profile® with a synbiotic product will lead to an increased overall wellbeing without compromising weight management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Mar 2017
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 29, 2017
CompletedFirst Posted
Study publicly available on registry
April 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedApril 21, 2017
April 1, 2017
5 months
March 29, 2017
April 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Gut microbiota associated to the synbiotic treatment
Stools samples will be collected and analyzed before and after the intervention and compared between groups
3 months
Secondary Outcomes (4)
Changes in weight associated to the synbiotic treatment
3 months
Changes in glucose levels associated to the synbiotic treatment
3 months
Changes in body density associated to the synbiotic treatment
3 months
Changes in waist circumference associated to the synbiotic treatment
3 months
Study Arms (2)
Synbiotic supplement
EXPERIMENTALBifidobacterium spp plus bimuno- galacto-oligosaccharides
placebo
PLACEBO COMPARATORsugar pills
Interventions
Volunteers will be asked to take one probiotic capsule and one prebiotic satchel daily.
Volunteers will be asked to take one placebo capsule and one placebo satchel daily.
Eligibility Criteria
You may qualify if:
- Any individual aged 18-80 years participating in the Profile weight loss/management diet
You may not qualify if:
- Pregnant
- Requires special diets or dietary regimens
- On long term antibiotic therapy
- Diagnosed with gastrointestinal diseases (Irritable Bowel syndrome, Crohn's disease or Colitis)
- Immune compromised
- Have cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- South Dakota State Universitylead
- Sanford Healthcollaborator
Study Sites (1)
South Dakota State University
Brookings, South Dakota, 57007, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
eduardo Huarte, PhD
South Dakota State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Neither the volunteers nor the coaches will be aware
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Reseacrh Professor
Study Record Dates
First Submitted
March 29, 2017
First Posted
April 21, 2017
Study Start
March 1, 2017
Primary Completion
July 31, 2017
Study Completion
November 1, 2017
Last Updated
April 21, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will share
Result of the study will be made available to the scientific community trough manuscript publication. Each participant will be assigned a code to maintain patient confidentiality.